Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Quantifying Fluorescently Labeled Ceramide Levels in Human Sarcoma Cell Lines in Response to a Sphingomyelin Synthase Inhibitor.

Pashikanti S, Afrin F, Meldrum TC, Stegelmeier JL, Pavek A, Habashi YA, Fatema K, Barrott JJ.

Methods Protoc. 2019 Aug 31;2(3). pii: E76. doi: 10.3390/mps2030076.

2.

Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma.

Mika A, Luelling SE, Pavek A, Nartker C, Heyneman AL, Jones KB, Barrott JJ.

J Clin Med. 2019 Mar 24;8(3). pii: E408. doi: 10.3390/jcm8030408.

3.

Sarcoma-The standard-bearer in cancer discovery.

Potter JW, Jones KB, Barrott JJ.

Crit Rev Oncol Hematol. 2018 Jun;126:1-5. doi: 10.1016/j.critrevonc.2018.03.007. Epub 2018 Mar 29. Review.

4.

Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.

Barrott JJ, Illum BE, Jin H, Hedberg ML, Wang Y, Grossmann A, Haldar M, Capecchi MR, Jones KB.

J Clin Invest. 2018 Jan 2;128(1):207-218. doi: 10.1172/JCI94955. Epub 2017 Nov 20.

5.

Death by HDAC Inhibition in Synovial Sarcoma Cells.

Laporte AN, Poulin NM, Barrott JJ, Wang XQ, Lorzadeh A, Vander Werff R, Jones KB, Underhill TM, Nielsen TO.

Mol Cancer Ther. 2017 Dec;16(12):2656-2667. doi: 10.1158/1535-7163.MCT-17-0397. Epub 2017 Sep 6.

6.

The Influential Role of BCL2 Family Members in Synovial Sarcomagenesis.

Barrott JJ, Zhu JF, Smith-Fry K, Susko AM, Nollner D, Burrell LD, Pozner A, Capecchi MR, Yap JT, Cannon-Albright LA, Deng X, Jones KB.

Mol Cancer Res. 2017 Dec;15(12):1733-1740. doi: 10.1158/1541-7786.MCR-17-0315. Epub 2017 Aug 29.

7.

The Impact of Microenvironment on the Synovial Sarcoma Transcriptome.

Jin H, Barrott JJ, Cable MG, Monument MJ, Lerman DM, Smith-Fry K, Nollner D, Jones KB.

Cancer Microenviron. 2017 Dec;10(1-3):1-7. doi: 10.1007/s12307-017-0192-y. Epub 2017 Apr 13.

8.

HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma.

Laporte AN, Barrott JJ, Yao RJ, Poulin NM, Brodin BA, Jones KB, Underhill TM, Nielsen TO.

PLoS One. 2017 Jan 5;12(1):e0169407. doi: 10.1371/journal.pone.0169407. eCollection 2017.

9.

Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation.

Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB.

J Exp Med. 2016 Dec 12;213(13):2989-3005. Epub 2016 Nov 9.

10.

LRP5 Signaling in Osteosarcomagenesis: a Cautionary Tale of Translation from Cell Lines to Tumors.

Horne L, Avilucea FR, Jin H, Barrott JJ, Smith-Fry K, Wang Y, Hoang BH, Jones KB.

Transl Oncol. 2016 Oct;9(5):438-444. doi: 10.1016/j.tranon.2016.08.010.

11.

The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.

Jones KB, Barrott JJ, Xie M, Haldar M, Jin H, Zhu JF, Monument MJ, Mosbruger TL, Langer EM, Randall RL, Wilson RK, Cairns BR, Ding L, Capecchi MR.

Oncogene. 2016 Sep 22;35(38):5021-32. doi: 10.1038/onc.2016.38. Epub 2016 Mar 7.

12.

β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition.

Barrott JJ, Illum BE, Jin H, Zhu JF, Mosbruger T, Monument MJ, Smith-Fry K, Cable MG, Wang Y, Grossmann AH, Capecchi MR, Jones KB.

Oncotarget. 2015 Sep 8;6(26):22758-66.

13.

Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells.

Barrott JJ, Hughes PF, Osada T, Yang XY, Hartman ZC, Loiselle DR, Spector NL, Neckers L, Rajaram N, Hu F, Ramanujam N, Vaidyanathan G, Zalutsky MR, Lyerly HK, Haystead TA.

Chem Biol. 2013 Sep 19;20(9):1187-97. doi: 10.1016/j.chembiol.2013.08.004. Epub 2013 Sep 12.

14.

Hsp90, an unlikely ally in the war on cancer.

Barrott JJ, Haystead TA.

FEBS J. 2013 Mar;280(6):1381-96. doi: 10.1111/febs.12147. Epub 2013 Feb 24. Review.

15.

A highly selective Hsp90 affinity chromatography resin with a cleavable linker.

Hughes PF, Barrott JJ, Carlson DA, Loiselle DR, Speer BL, Bodoor K, Rund LA, Haystead TA.

Bioorg Med Chem. 2012 May 15;20(10):3298-305. doi: 10.1016/j.bmc.2012.03.043. Epub 2012 Mar 29.

16.

Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome.

Barrott JJ, Cash GM, Smith AP, Barrow JR, Murtaugh LC.

Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12752-7. doi: 10.1073/pnas.1006437108. Epub 2011 Jul 18.

Supplemental Content

Loading ...
Support Center